Yuyu to appeal Fosamax Plus case to patent court

Published: 2007-12-19 06:59:00

Updated: 2007-12-19 06:59:00

Yuyu Pharm plans to file its lawsuit against MSD Korea to confirm the patent claims of Fosamax Plus in a patent court, after the Korean Intellectual Property Tribunal decided to reject Yuyu's claim that Fosamax Plus infringe on Maxmarvil (alendronate sodium plus calcitriol) patent.

Yuyu lodged its lawsuit against MSD Korea in June last year, claiming that Fosamax Plus infringed the patent of...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.